Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Estimated Value: $275,000
Open 551 days left Healthcaregrant
Nov 22, 2024
Jan 7, 2028 12:00 AM
Healthcare
grant
...
AI Summary
This grant opportunity, PAR-25-282, focuses on mood and psychosis symptoms during the menopause transition. It is an R21 Clinical Trial Optional grant, with CFDA numbers 93.242 and 93.313.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Research Personnel (Principal Investigator, Co-Investigators, Research Assistants, etc.) 1 lot $100,000.00 $100,000.00 Professional Services
Participant Recruitment and Retention 1 lot $25,000.00 $25,000.00 Medical
Data Collection and Analysis (including software and statistical consulting) 1 lot $50,000.00 $50,000.00 IT Services
Clinical Assessments and Diagnostic Testing 1 lot $50,000.00 $50,000.00 Medical
Publication and Dissemination Costs 1 lot $10,000.00 $10,000.00 Professional Services
Institutional Overhead (Indirect Costs) 1 lot $40,000.00 $40,000.00 Other
Estimated Bid Value$275,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids